Join the 'Oseltamivir' group to help and get support from people like you.
Oseltamivir Blog
| Tweet |
'Spot' Shortages of Flu Vaccine, Tamiflu Reported, FDA Head Says
Posted 15 Jan 2013 by Drugs.com
TUESDAY, Jan. 15 – Sporadic shortages of both the flu vaccine and the flu treatment Tamiflu are being reported, as this year's intense flu season continues, according to a top U.S. health official. "We have received reports that some consumers have found spot shortages of the vaccine," Dr. Margaret Hamburg, commissioner of the U.S. Food and Drug Administration, said Monday on her blog on the agency's website. Hamburg said that the agency is "monitoring this situation and will update you at our website and at www.flu.gov." So far, more than 128 million doses of flu vaccine have been distributed, Hamburg said, but not all the doses have been administered to people yet. She said that people who already have the flu may also be experiencing local shortages of Tamiflu, a drug that can help treat influenza. "We do anticipate intermittent, temporary shortages of the oral suspension form of ... Read more
Related support groups: Influenza, Tamiflu, Oseltamivir, FluLaval, Afluria, Fluzone, Flushield, Influenza Prophylaxis, Flucelvax, Fluzone WV, Fluogen, Fluvirin, Influenza Virus Vaccine, Inactivated, Fluzone PFS, Agriflu
FDA Expands Tamiflu's Use to Treat Children Younger Than One Year
Posted 21 Dec 2012 by Drugs.com
December 21, 2012 – The U.S. Food and Drug Administration today expanded the approved use of Tamiflu (oseltamivir) to treat children as young as 2 weeks old who have shown symptoms of flu for no longer than two days. The drug is not approved to prevent flu infection in this population. In addition, the safety and efficacy of Tamiflu to treat flu infection has not been established in children younger than 2 weeks old. Tamiflu was approved in 1999 to treat adults infected with flu who have shown symptoms for no longer than two days. It has since been approved to treat flu in children ages 1 year and older who have shown symptoms of flu for no longer than two days, and to prevent flu in adults and children ages 1 year and older. Although there is a fixed dosing regimen for patients 1 year and older according to weight categories, the dosing for children younger than 1 year must be ... Read more
Related support groups: Influenza, Tamiflu, Swine Influenza, Oseltamivir, Swine Flu, Influenza Prophylaxis, Flu Prevention, Flu
Cases of Tamiflu-Resistant Flu Concern Experts
Posted 28 Dec 2011 by Drugs.com
WEDNESDAY, Dec. 28 – World Health Organization researchers are reporting an apparent spike in Australia in the number of seasonal influenza cases resistant to Tamiflu, the most commonly used antiviral drug. The jump in such cases involving the pandemic 2009 A(H1N1) flu strain, also known as swine flu, took place during Australia's most recent winter: May through August of 2011. "In 2007/2008, a different A(H1N1) influenza virus developed Tamiflu-resistance," explained WHO research scientist Aeron C. Hurt, who reported the spike. "On that occasion, it was first detected in large numbers in Europe. However, within 12 months the virus had spread globally, such that virtually every A(H1N1) virus around the world was resistant to this drug," he explained. "This previous situation demonstrated the speed and potential for a Tamiflu-resistant virus to spread worldwide," Hurt added. "Our ... Read more
Related support groups: Tamiflu, Swine Influenza, Oseltamivir
FDA Warns About Fraudulent Tamiflu
Posted 18 Jun 2010 by Drugs.com
Fraudulent product is dangerous to patients allergic to penicillin ROCKVILLE, Md., June 17, 2010--The U.S. Food and Drug Administration today warned consumers about a potentially harmful product represented as “Generic Tamiflu” sold over the Internet. FDA tests revealed that the fraudulent product does not contain Tamiflu’s active ingredient, oseltamivir, but cloxacillin, an ingredient in the same class of antibiotics as penicillin. The agency reminds patients who are allergic to or may have experienced adverse reactions from penicillin products that they are at risk of experiencing similar reactions from cloxacillin. This includes a sudden, potentially life-threatening reaction called anaphylaxis, with symptoms that include difficulty breathing, chest tightness, swelling of the throat or tongue, hives, dizziness, loss of consciousness, or a rapid or weak pulse. To date, the FDA is not a ... Read more
Related support groups: Tamiflu, Oseltamivir
Ask a Question
Further Information
Related Condition Support Groups
Influenza, Swine Influenza, Influenza Prophylaxis, Avian Influenza